Kevin Michael Krause

Companies

• AN2 Therapeutics, Inc.Chief Strategy Officer Mar 24, 2022 to Mar 29, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAN2 Therapeutics, Inc. ANTX31,914 shares²$104.4K at $3.27Mar 15, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 15, 2024Granted 30,000 shares of AN2 Therapeutics, Inc.²
• Mar 15, 2024Granted 30,000 shares of AN2 Therapeutics, Inc.³
• Jan 9, 2024Sold 7,417 shares at $20.14 of AN2 Therapeutics, Inc.⁴
• Jan 9, 2024Exercised options 5,000 shares at $6.60 of AN2 Therapeutics, Inc.⁴
• Jan 9, 2024Exercised options 2,417 shares at $0.42 of AN2 Therapeutics, Inc.⁴
• Jan 2, 2024Sold 2,583 shares at $20.12 of AN2 Therapeutics, Inc.⁵
• Jan 2, 2024Exercised options 2,583 shares at $0.42 of AN2 Therapeutics, Inc.⁵